Neuland Laboratories Ltd. (IN:NEULANDLAB)
:NEULANDLAB
Want to see IN:NEULANDLAB full AI Analyst Report?
Total Valuation
Neuland Laboratories Ltd. has a market cap or net worth of ₹213.32B. The enterprise value is ₹212.75B.
Market Cap₹213.32B
Enterprise Value₹212.75B
Share Statistics
Neuland Laboratories Ltd. has 12,829,889 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,829,889
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Neuland Laboratories Ltd.’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 15.90%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)15.90%
Return on Capital Employed (ROCE)0.22
Revenue Per Employee12.31M
Profits Per Employee2.22M
Employee Count1,643
Asset Turnover0.69
Inventory Turnover2.70
Valuation Ratios
The current PE Ratio of Neuland Laboratories Ltd. is 42.4. Neuland Laboratories Ltd.’s PEG ratio is 1.06.
PE Ratio42.4
PS Ratio7.63
PB Ratio8.23
Price to Fair Value8.23
Price to FCF-262.04
Price to Operating Cash Flow-580.42
PEG Ratio1.06
Income Statement
In the last 12 months, Neuland Laboratories Ltd. had revenue of 20.23B and earned 3.64B in profits. Earnings per share was 283.71.
Revenue20.23B
Gross Profit6.43B
Operating Income4.83B
Pretax Income4.89B
Net Income3.64B
EBITDA5.74B
Earnings Per Share (EPS)283.71
Cash Flow
In the last 12 months, operating cash flow was -367.47M and capital expenditures -1.71B, giving a free cash flow of -2.07B billion.
Operating Cash Flow-367.47M
Free Cash Flow-2.07B
Free Cash Flow per Share-161.73
Dividends & Yields
Neuland Laboratories Ltd. pays an annual dividend of ₹12, resulting in a dividend yield of 0.08%
Dividend Per Share₹12
Dividend Yield0.08%
Payout Ratio7.70%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.32
52-Week Price Change48.75%
50-Day Moving Average14.25K
200-Day Moving Average14.73K
Relative Strength Index (RSI)61.68
Average Volume (3m)2.41K
Important Dates
Neuland Laboratories Ltd. upcoming earnings date is Jul 30, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Neuland Laboratories Ltd. as a current ratio of 2.09, with Debt / Equity ratio of 16.07%
Current Ratio2.09
Quick Ratio1.37
Debt to Market Cap0.01
Net Debt to EBITDA-0.09
Interest Coverage Ratio20.16
Taxes
In the past 12 months, Neuland Laboratories Ltd. has paid 1.25B in taxes.
Income Tax1.25B
Effective Tax Rate0.26
Enterprise Valuation
Neuland Laboratories Ltd. EV to EBITDA ratio is 26.77, with an EV/FCF ratio of -261.13.
EV to Sales7.60
EV to EBITDA26.77
EV to Free Cash Flow-261.13
EV to Operating Cash Flow45.46
Balance Sheet
Neuland Laboratories Ltd. has ₹1.80B in cash and marketable securities with ₹2.65B in debt, giving a net cash position of -₹848.70M billion.
Cash & Marketable Securities₹1.80B
Total Debt₹2.65B
Net Cash-₹848.70M
Net Cash Per Share-₹66.15
Tangible Book Value Per Share₹1.24K
Margins
Gross margin is 47.07%, with operating margin of 23.86%, and net profit margin of 17.99%.
Gross Margin47.07%
Operating Margin23.86%
Pretax Margin24.17%
Net Profit Margin17.99%
EBITDA Margin28.40%
EBIT Margin23.86%
Analyst Forecast
The average price target for Neuland Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast36.98%
EPS Growth Forecast39.94%